Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Director departure
Adverum Biotechnologies, Inc. (ADVM) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "Adverum Biotechnologies Completes Enrollment of Phase 2 LUNA Trial in Wet AMD and Reports Second Quarter 2023 Financial Results"
08/04/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
07/24/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/09/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/25/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/19/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/11/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Sales Agreement",
"Opinion of Cooley LLP"
05/11/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "Adverum Biotechnologies Reports First Quarter 2023 Financial Results"
05/03/2023 EFFECT Form EFFECT - Notice of Effectiveness:
04/25/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
04/25/2023 ARS Form ARS - Annual Report to Security Holders:
04/25/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/25/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/20/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
04/14/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G BANK OF AMERICA CORP reports a 5.6% stake in Adverum Biotechnologies, Inc.
02/09/2023 SC 13G/A FMR LLC reports a 7.8% stake in ADVERUM BIOTECHNOLOGIES INC
02/08/2023 SC 13G/A BML Investment Partners, L.P. reports a 7.3% stake in Adverum Biotechnologies, Inc.
02/08/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/30/2022 SC 13D/A Sonic Fund II, L.P. reports a 4.6% stake in Adverum Biotechnologies, Inc.
12/13/2022 8-K Quarterly results
11/23/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
11/10/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/10/2022 8-K Quarterly results
09/02/2022 SC 13G Soleus Capital Master Fund, L.P. reports a 5% stake in Adverum Biotechnologies, Inc.
08/11/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/11/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/11/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy